Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19. Read more about Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19.
Structural and mechanistic insights into a lysosomal membrane enzyme HGSNAT involved in Sanfilippo syndrome. Read more about Structural and mechanistic insights into a lysosomal membrane enzyme HGSNAT involved in Sanfilippo syndrome.
Small molecule in situ resin capture provides a compound first approach to natural product discovery. Read more about Small molecule in situ resin capture provides a compound first approach to natural product discovery.
Ambient air pollution and urological cancer risk: A systematic review and meta-analysis of epidemiological evidence. Read more about Ambient air pollution and urological cancer risk: A systematic review and meta-analysis of epidemiological evidence.
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling. Read more about Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
Fate of telomere entanglements is dictated by the timing of anaphase midregion nuclear envelope breakdown. Read more about Fate of telomere entanglements is dictated by the timing of anaphase midregion nuclear envelope breakdown.
Validation of human telomere length multi-ancestry meta-analysis association signals identifies POP5 and KBTBD6 as human telomere length regulation genes. Read more about Validation of human telomere length multi-ancestry meta-analysis association signals identifies POP5 and KBTBD6 as human telomere length regulation genes.
Illuminating the function of the orphan transporter, SLC22A10, in humans and other primates. Read more about Illuminating the function of the orphan transporter, SLC22A10, in humans and other primates.
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer. Read more about Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer.
VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance. Read more about VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance.
